Pancreatic cancer: A plea for good and comprehensive morphological studies

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 8, 2008, Pages 713-715

  Algül, Hana ^a   Schmid, Roland M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cycloxygenase 2; P53; Pancreatic cancer; Pancreatic intraepithelial neoplasia; Progression model

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; CYCLOOXYGENASE 2; PROTEIN P53; PTGS2 PROTEIN, HUMAN; TUMOR MARKER;

ARF GENE; ARTICLE; BRCA2 GENE; CANCER GROWTH; CANCER INVASION; CANCER MORPHOLOGY; CANCER STAGING; CARCINOGENESIS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; INK4A GENE; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS; SMAD4 GENE; TP53 GENE; TUMOR SUPPRESSOR GENE; METABOLISM; NOTE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PRECANCER;

CARCINOMA, PANCREATIC DUCTAL; CYCLOOXYGENASE 2; HUMANS; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 52749099544     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f9460e     Document Type: Article

References (18)

1. Aung KL, Smith DB, Neoptolemos JP. Adjuvant therapy for pancreatic cancer. Expert Opin Pharmacother 2007; 8:2533-2541.
2. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20:1218-1249.
3. Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE, et al. Pancreatic cancer. Curr Probl Cancer 2002; 26:176-275.
4. Tuveson DA, Hingorani SR. Ductal pancreatic cancer in humans and mice. Cold Spring Harb Symp Quant Biol 2005; 70:65-72.
5. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol 2000; 156:1821-1825.
6. Sommers SC, Meissner WA. Unusual carcinomas of the pancreas. AMA Arch Pathol 1954; 58:101-111.
7. Hruban RH, Takaori K, Canto M, Fishman EK, Campbell K, Brune K, et al. Clinical importance of precursor lesions in the pancreas. J Hepatobiliary Pancreat Surg 2007; 14:255-263.
8. Hruban RH, Rustgi AK, Brentnall TA, Tempero MA, Wright CV, Tuveson DA. Pancreatic cancer in mice and man: the Penn Workshop 2004. Cancer Res 2006; 66:14-17.
9. Hermanova M, Trna J, Nenutil R, Dite P, Kala Z. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. Eur J Gastroenterol Hepatol 2008; 20:732-739.
10. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999; 59:987-990.
11. Koshiba T, Hosotani R, Miyamoto Y, Wada M, Lee JU, Fujimoto K, et al. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int J Pancreatol 1999; 26:69-76.
12. Okami J, Yamamoto H, Fujiwara Y, Tsujie M, Kondo M, Noura S, et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 1999; 5:2018-2024.
13. Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 2000; 21:139-146.
14. Kokawa A, Kondo H, Gotoda T, Ono H, Saito D, Nakadaira S, et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 2001; 91:333-338.
15. Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo CJ, Sohn TA, et al. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol 2002; 118:194-201.
16. Xu L, Li YM, Yu CH, Li L, Liu YS, Zhang BF, et al. Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray. Hepatobiliary Pancreat Dis Int 2006; 5:138-142.
17. Olive KP, Tuveson DA. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin Cancer Res 2006; 12:5277-5287.
18. Muller-Decker K, Furstenberger G, Annan N, Kucher D, Pohl-Arnold A, Steinbauer B, et al. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Gastroenterology 2006; 130:2165-2178.